Enzymes called proteases act like molecular scissors for proteins in the body and play a role in therapies to stop viruses from replicating and to kill cancer cells. The development of these medicines ...

Boundless Bio made a play to become the seventh US biotech to seek a public listing in 2024, ending a brief hiatus in IPO activity after a busy start to the year. The specialist in cancer therapies ...

Fashion for Good says mass balance could provide a “practical bridge”, allowing brands to integrate renewable materials in a cost-effective and scalable way ...

Scientists at Exxon Mobil (XOM) told one of the company’s top strategic planning executives in early 2020 that a $500M algae biofuels program was falling well short of its stated goals, The Wall ...

SK Hynix said in a filing that it aims to proceed with a U.S. listing within 2026. However, details such as the size, method, and schedule of the public offering have not yet been finalized. SK Hynix ...

Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...

File syncing and storage services, also known as cloud storage services, offer major convenience. They let you back up and access your data—documents, photos, video, and other file types—on any ...

ANN ARBOR, Mich., March 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today ...

Technology isn’t the biggest challenge. Culture is. by Tim Fountaine, Brian McCarthy and Tamim Saleh Artificial intelligence is reshaping business—though not at the blistering pace many assume. True, ...